ACKERMANS + VAN HAAREN/ BE0003764785 /
26/04/2024 08:00:29 | Var. +0.20 | Volume | Denaro20:51:10 | Lettera20:51:10 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
158.80EUR | +0.13% | 0 Fatturato: 0.00 |
-Quantità in denaro: - | -Quantità in lettera: - | 5.44 bill.EUR | 2.12% | 13.23 |
Newsfile Corp
03:20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocu...
GlobeNewswire
02:40
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to ...
GlobeNewswire
02:17
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with L...
Newsfile Corp
01:11
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Se...
Newsfile Corp
28/04
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Befor...